19Dec
As its COVID-19 Vaccine Nears Finalization, AstraZeneca Announces Deal to Buy Alexion for $39 Billion
AstraZeneca, the British-Swedish multinational pharmaceutical company currently collaborating with the University of Oxford on a COVID-19 vaccine, will purchase Alexion Pharmaceuticals for $39 billion. The transaction, which awaits approval by shareholders and regulators, is the largest purchase by a health care company this year and is expected to close in the third quarter of 2021. Alexion was founded in 1992 and is headquartered in Boston but has a global presence. It is known for its...
By:
Rothwell, Figg, Ernst & Manbeck, P.C.
Related
According to the Internal Revenue Service (IRS), the best way for an employer to avoid 401(k) plan m...
Read More >
An IT consulting company based in Southern California recently paid $48,193 to one employee after th...
Read More >
Time and money are often seen as going hand in hand in construction contracts. In a typical employer...
Read More >
The EU has granted the UK another extension for the Brexit process, giving Britain until January 31 ...
Read More >
Mid-December is always a time where one can expect significant decisions to issue from the NLRB. In ...
Read More >
Both workers and retirees may need to rethink some of their estate planning in light of the newest s...
Read More >